VRDN (VRDN) Stock Price & Analysis
VRDN (VRDN) fell 0.17% to USD 22.92 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
VRDN last closed at USD 22.92; the session ranged USD 22.62–23.03 on volume of 759,915 shares. Market capitalization is —, with a 52-week range of USD 13.18–34.29 (NCM). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 22.92 |
|---|---|
| Change | ▼ 0.17% (down) |
| Previous Close | USD 22.92 |
| Open | USD 22.92 |
| Day Range | USD 22.62 – 23.03 |
| 52-Week Range | USD 13.18 – 34.29 |
| Volume | 759,915 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VRDN)
Nexqual's technical model rates VRDN "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 55.23 (neutral) |
| vs SMA50 | Above (USD 21.08) |
| MACD | 0.59 (positive) |
From VRDN's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| TVTX | Travere Therapeutics, Inc. | USD 65.28 | ▼ 2.9% |
| IDYA | IDEAYA Biosciences, Inc. | USD 39.86 | ▼ 0.77% |
| VERA | Vera Therapeutics, Inc. | USD 35.89 | ▲ 0.64% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.